Metastatic Burden Defines Clinically and Biologically Distinct Subgroups of Stage 4 High-Risk Neuroblastoma

Metastatic Burden Defines Clinically and Biologically Distinct Subgroups of Stage 4 High-Risk Neuroblastoma

This study aimed to identify the prognostic subgroups of stage 4 high-risk neuroblastoma based on metastatic burden and explore their distinct clinical and genomic features. Patients aged ≥18 months with stage 4 and metaiodobenzylguanidine-avid neuroblastoma were enrolled. One hundred and thirty eli...

Full description

Bibliographic Details
Main Authors: Eun Seop Seo, Eun-jin Lee, Boram Lee, Muheon Shin, Young-Seok Cho, Ju Kyung Hyun, Hee Won Cho, Hee Young Ju, Keon Hee Yoo, Hong Hoe Koo, Ji Won Lee, Ki Woong Sung
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Journal of Clinical Medicine
Subjects:
high-risk neuroblastoma
metastasis
prognosis
tandem transplant
Online Access:https://www.mdpi.com/2077-0383/9/9/2730

Internet

https://www.mdpi.com/2077-0383/9/9/2730

Similar Items